PSUSA/00000592/202503
PSUSA/00000592/202503
PSUSA/00000592/202503
EMEA-003402-PIP01-23
Human medicines European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira), pemetrexed, Date of authorisation: 19/11/2015, Revision: 19, Status: Authorised
Q&A Clinic - New Variation Classification in eAF , Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 January 2026, 10:00 (CET) to 8 January 2026, 11:00 (CET)
Human medicines European public assessment report (EPAR): Verkazia, ciclosporin, Date of authorisation: 06/07/2018, Revision: 8, Status: Authorised
Minutes of the COMP meeting 4-6 November 2025
3-year rolling work plan for the Quality Innovation Group (QIG) 2026-2028
Medicine evaluation figures
Human medicines in 2025
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure